Liposomal Doxorubicin and Docetaxel in Metastatic Breast Cancer

Clinical trial NCT00524810 · COMPLETED

Trial details

NCT number: NCT00524810
Sponsor: ARCAGY/ GINECO GROUP
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Breast Cancer

Start date: 2004-02-01
Primary completion: 2009-06-01
Enrollment: 67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.